Xiaojie Xun

533 citations
17 papers · 440 indexed · h-index 11
Topics
Pharmacogenetics and Drug Metabolism (3 papers)Nicotinic Acetylcholine Receptors Study (2 papers)Radiation Therapy and Dosimetry (2 papers)
Partner nations
ChinaUnited StatesMexico

In The Last Decade

Xiaojie Xun

17 papers receiving 436 citations

Peers

Xiaojie Xun
Comparison fields: 5 of 85
  • Biomedical Engineering 198
  • Molecular Biology 133
  • Materials Chemistry 108
  • Biomaterials 101
  • Pulmonary and Respiratory Medicine 70
Replace Minghua Yao with:
Minghua Yao China
Justin Hubenak United States
Mark Martin Jensen United States
Paul Lyon United Kingdom
Rabee Cheheltani United States
Marcelo Coutinho de Miranda Brazil
Long Yuan China
G. Kate Park United States
Haijiao Mao China
Wen Song China
Xiaojie Xun relative to Minghua Yao China Minghua Yao's profile →
Citations per field
00.5×1.5×
Minghua Yao · 1×
Citations per year

Countries citing papers authored by Xiaojie Xun

Since Specialization
Citations

This map shows the geographic impact of Xiaojie Xun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Xun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Xun more than expected).

Fields of papers citing papers by Xiaojie Xun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojie Xun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Xun. The network helps show where Xiaojie Xun may publish in the future.

Co-authorship network of co-authors of Xiaojie Xun

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojie Xun. A scholar is included among the top collaborators of Xiaojie Xun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojie Xun. Xiaojie Xun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 42
2 37
3 34
4 16
5 189
6 12
7 3
8 1
9 6
10 10
11 25
12 6
13
CHRNA5 polymorphisms and risk of lung cancer in Chinese Han smokers.
14
14 4
15 16
16 15
17 10

About Xiaojie Xun

Xiaojie Xun is a scholar working on Pharmacology, Biochemistry and Cancer Research, having authored 17 papers that have together received 440 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and Radiation Therapy and Dosimetry (2 papers). The work is most often cited by research in Biomaterials (101 citations), Biomedical Engineering (198 citations) and Molecular Medicine (15 citations). Xiaojie Xun has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Ming Su, Junjie Deng, Liyuan Zheng, Shandong Xu, Tingting Geng, Tianbo Jin, Zhiyuan Fan, Ping Li, Peng Hou and Qingxuan Li. Their work appears in journals such as PLoS ONE, Biomaterials and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026